Drawing as a Measurement of Dental Anxiety
Launched by TRAKYA UNIVERSITY · Mar 11, 2020
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
Background: Drawings can be used as a method of communication that represents an individual's self-concept, anxiety, attitude, or conflict.
Aim: The purpose of this study was to evaluate children's drawing as a measure of dental anxiety in a dental setting.
Design: Seventy- eight children, aged 6-12 years, were enrolled in this study. Pulp therapy and/or restorative treatment was performed during the first therapeutic session for all participants. Sound, Eye, and Motor (SEM) and Frankl scales were used as an objective assessment of dental anxiety during treatment. After the treatment sess...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 6-12 years of age-independent of sex, and ethnic characteristics
- • Children without previous dental treatment experience.
- • Children with carious primary teeth which required pulp therapy and restorative treatment
- • Children who are not considered medically compromised
- • Obtained written informed consent from parents or caregivers and obtained verbal informed consent from the child for their participance in the study where procedures are explained in an age-appropriate attitude
- • Children who accept to draw a picture
- Exclusion Criteria:
- • Children with a compromised physical and mental health history
- • Children who already received dental treatments
- • Children who only needed preventive treatments
- • Children who reject to draw a picture
About Trakya University
Trakya University is a leading academic institution located in Edirne, Turkey, dedicated to advancing health sciences through innovative research and education. With a strong emphasis on clinical trials, the university fosters collaboration between researchers, healthcare professionals, and industry partners to facilitate groundbreaking studies that enhance patient care and medical knowledge. Trakya University's commitment to ethical standards, rigorous scientific methodology, and community engagement positions it as a key player in the landscape of clinical research, contributing to the development of novel therapeutic interventions and improving health outcomes in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials